The basal ganglia matching tools package for striatal uptake semi-quantification: Description and validation

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 34, Issue 8, 2007, Pages 1240-1253

  Calvini, Piero ^a   Rodriguez, Guido ^b   Inguglia, Fabrizio ^b   Mignone, Alessandro ^c   Guerra, Ugo Paolo ^c   Nobili, Flavio ^b  

^a INFM   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c OSPEDALI RIUNITI   (Italy)

Author keywords

123I FP CIT SPECT; Anthropomorphic brain phantom; Automatic VOIs; Basal ganglia; Nigrostriatal system; Parkinson's disease

Indexed keywords

FP CIT I 123; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUTOMATION; BASAL GANGLION; BRAIN REGION; CAUDATE NUCLEUS; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; CORPUS STRIATUM; ELECTROENCEPHALOGRAM; ESSENTIAL TREMOR; FEMALE; HUMAN; KERNEL METHOD; MALE; NEUROIMAGING; PARKINSON DISEASE; PUTAMEN; RADIATION MEASUREMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THREE DIMENSIONAL IMAGING; VALIDATION STUDY;

ALGORITHMS; ANIMALS; AUTOMATION; BASAL GANGLIA; CORPUS STRIATUM; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; IODINE RADIOISOTOPES; NORMAL DISTRIBUTION; PHANTOMS, IMAGING; SOFTWARE; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 34548079251     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-006-0357-2     Document Type: Article

References (28)

1. 123I-FP-CIT Study Group. Mov Disord 2000;15:503-10.
2. O'Brien JT, Colloby S, Fenwick J, Williams ED, Firbank M, Burn D, et al. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Arch Neurol 2004;61:919-25.
3. Chouker M, Tatsch K, Linke R, Pogarell O, Hahn K, Schwarz J. Striatal dopamine transporter binding in early to moderate advanced Parkinson's disease: monitoring of disease progression over 2 years. Nucl Med Commun 2001;22:721-5.
4. Marek K, Seibyl J, Shoulson I. Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression. JAMA 2002;287:1653-61.
5. Acton PD, Pilowsky LS, Kung HF, Ell PJ. Automatic segmentation of dynamic neuroreceptor single-photon emission tomography images using fuzzy clustering. Eur J Nucl Med 1999;26:581-90.
6. Acton PD, Mozley PD, Kung HF. Logistic discriminant parametric mapping: a novel method for the pixel-based differential diagnosis of Parkinson's disease. Eur J Nucl Med 1999;26:1413-23.
7. Koole M, Laere KV, De Walle RV, Vandenberghe S, Bouwens L, Lemahieu I, et al. MRI guided segmentation and quantification of SPECT images of the basal ganglia: a phantom study. Comput Med Imaging Graph 2001;25:165-72.
8. Habraken JBA, Booij J, Slomka P, Sokole EB, van Royen EA. Quantification and visualization of defects of the functional dopaminergic system using an automatic algorithm. J Nucl Med 1999;40:1091-7.
9. 123I-IBZM uptake in the striatum applied to parkinsonism. J Nucl Med 2000;41:220-7.
10. Koch W, Radau PE, Hamann C, Tatsch K. Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies. J Nucl Med 2005;46:1109-18.
11. http://www.disi.unige.it/person/IngugliaF/BasGan/
12. Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain. New York: Thieme Medical, 1988.
13. Hudson HM, Larkin RS. Accelerated image reconstruction using ordered subsets of projection data. IEEE Trans Med Imag 1994;13:601-9.
14. Boccacci P, Bonetto P, Calvini P, Formiconi AR. A simple model for the the efficient correction of collimator blur in 3D SPECT imaging. Inverse Problems 1999;15:907-30.
15. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson's disease. Arch Neurol 1999;56:33-9.
16. Deuschl G, Bain P, Brin M; Ad Hoc Scientific Committee. Consensus statement of the Movement Disorder Society on tremor. Mov Disord 1998;13(suppl 3):2-23.
17. 123I-labelled dopamine D2 receptor ligands. Eur J Nucl Med Mol Imaging 2002;29:BP23-9.
18. Hamann C, Koch W, Radau PE, Tatsch K. Iterative reconstruction or filtered backprojection for quantitative assessment of dopamine d2 receptor studies? J Nucl Med 2003;44:114P.
19. Koch W, Radau PE, Münzing W, Tatsch K. Cross-camera comparison of SPECT measurements of a 3-D anthropomorphic basal ganglia phantom. Eur J Nucl Med Mol Imaging 2006;33:495-502.
20. 123I SPECT. J Nucl Med 2003;44:1184-93.
21. Soret M, Koulibaly PM, Darcourt J, Buvat I. Partial volume effect correction in SPECT for striatal uptake measurements in patients with neurodegenerative diseases: impact upon patient classification. Eur J Nucl Med Mol Imaging 2006;33:1062-72.
22. Ogawa K, Harata Y, Ichihara T, Kubo A, Hashimoto N. A practical method for position-dependent Compton-scattered correction in single photon emission. IEEE Trans Med Imaging 1991;10:408-12.
23. Dallal GE. The little handbook of statistical practice. http://www.tufts.edu/~gdallal/LHSP.HTM at the page http://www.tufts.edu/ ~gdallal/corr.htm
24. 123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease. Ann Neurol 1995;38:589-98.
25. Carmack PS, Spence J, Gunst RF, Schucany WR, Woodward WA, Haleyb RW. Improved agreement between Talairach and MNI coordinate spaces in deep brain regions. NeuroImage 2004;22:367-71.
26. 123I-FP-CIT SPECT in dementia with Lewy bodies, Alzheimer's disease and Parkinson's disease. NeuroImage 2004;23:956-66.
27. Van Laere K, Koole M, D'Asseler Y, Versijpt J, Audenaert K, Dumont F, et al. Automated stereotactic standardization of brain SPECT receptor data using single-photon transmission images. J Nucl Med 2001;42:361-75.
28. 11C-2-beta-carbomethoxy-3- beta-(4-fluorophenyl)-tropane in patients with movement disorders. Nucl Med Commun 2002;23:1047-55.